Imagen de Portada

Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Abdallah Mughrabi, Supavit Chesdachai, Bismarck Bisono Garcia, Adley Lemke, Nischal Ranganath, Raymund R. Razonable
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Clinical Transplantation
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
por: Vaisak O. Nair, et al.
Publicado: (2025)

Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
por: Suneri J. Amin, et al.
Publicado: (2025)

Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
por: Lemuel R. Non, et al.
Publicado: (2024)

De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)

Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
por: John‐Anthony Coppola, et al.
Publicado: (2025)

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
por: Margaret R. Jorgenson, et al.
Publicado: (2024)

Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
por: Estela Giménez, et al.
Publicado: (2025)

A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients
por: Afolarin A. Otunla, et al.
Publicado: (2026)

Infection Prevention and Surveillance in the Care of Australasian Solid‐Organ Transplant Recipients
por: Priya Garg, et al.
Publicado: (2025)

Utilization of a CMV T Cell Immunity Assay to Guide Secondary Prophylaxis in Solid Organ Transplant Recipients
por: Christina Doligalski, et al.
Publicado: (2026)

De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)

Updates on Vaccine‐Preventable Respiratory Viral Infections in Pediatric Solid Organ Transplant Recipients
por: Sanya J. Thomas, et al.
Publicado: (2025)

Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause‐or‐Consequence Dilemma
por: Renato Pascale, et al.
Publicado: (2026)

Chronic Antibiotic Prophylaxis to Prevent Recurrent Cholangitis in Liver Transplant Recipients
por: Florence Runyo, et al.
Publicado: (2025)

Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants
por: Kevin D. He, et al.
Publicado: (2024)

International Survey on Antibiotic Prophylaxis Approaches for Solid Organ Transplant Recipients and Donors Colonized With Multidrug‐Resistant Organisms
por: Julia Bini Viotti, et al.
Publicado: (2025)

Persisting Gaps in Cytomegalovirus Prevention and Management After Solid Organ Transplantation in a Resource‐Limited Setting
por: Guilherme Santoro‐Lopes, et al.
Publicado: (2025)

The Clinical Impact of Antibiotic Allergy Labels on One‐Year Outcomes of Solid Organ Transplant Recipients
por: Sashi Niranjan Nair, et al.
Publicado: (2026)

Disparities in Access to Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk African American Kidney Transplant Patients
por: Shipra R. Bethi, et al.
Publicado: (2024)

Prolonged Trimethoprim–Sulfametoxazole Prophylaxis in Kidney Transplant Recipients: Is it Justified by the “Collateral Benefits”?
por: Belén Gutierrez‐Gutierrez, et al.
Publicado: (2025)

Study of Sexual Health in Peri and Postmenopausal Solid Organ Transplant Recipients
por: Mona Polavarapu, et al.
Publicado: (2026)

Pneumocystis jiroveci Pneumonia Infections in Pediatric Solid Organ Transplant Recipients
por: Emily A. Hayes, et al.
Publicado: (2025)

Toxoplasmosis Prophylaxis Practices: A Survey of International Pediatric Solid Organ Transplantation Centers
por: Benjamin R. Hanisch, et al.
Publicado: (2025)

An Update on Invasive Fungal Infections in Solid Organ Transplant Recipients
por: Tina Marinelli, et al.
Publicado: (2026)

Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant
por: Mario M. Landa, et al.
Publicado: (2025)

A Matched Case‐Control Study to Evaluate Predicted Drug Exposures and Neutropenia during Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients
por: Mai‐Uyen T. Nguyen, et al.
Publicado: (2025)

Correlation Between Health Literacy and Tacrolimus Variability in Solid Organ Transplant Recipients
por: Astrid Bacle, et al.
Publicado: (2025)

Ionizing Radiation Exposure From Imaging in Pediatric Solid Organ Transplant Recipients
por: Cal H. Robinson, et al.
Publicado: (2026)

Unravelling the Mystery: Abdominal Pain in a Solid Organ Transplant Recipient
por: Siti Mardhiah Muhamad Fauzi, et al.
Publicado: (2025)

Clinical Characteristics and Outcomes of Pneumocystis Pneumonia in Solid Organ Transplant Recipients
por: Aaron M. Pulsipher, et al.
Publicado: (2026)

Clinically Significant EBV Infection in Allogeneic Stem Cell Transplanted Children Receiving Letermovir as Primary CMV Prophylaxis
por: Christina Oikonomopoulou, et al.
Publicado: (2025)

Discordance in serology for cytomegalovirus, Epstein‐Barr virus and toxoplasma among thoracic organ donors
por: Chia‐Yu Chiu, et al.
Publicado: (2024)

Measles and Solid Organ Transplantation: Diagnosis, Treatment, and Prevention
por: Stephanie M. Pouch, et al.
Publicado: (2025)

Kidney Allograft Outcomes of Dual‐Organ Heart Kidney Transplant Recipients Following Donation After Circulatory Determination of Death
por: Ananya Gorrai, et al.
Publicado: (2026)

Transmission of Ehrlichia chaffeensis From an Organ Donor to a Kidney–Pancreas Transplant Recipient
por: Praveen Gundelly, et al.
Publicado: (2025)

Impact of Pretransplant Antimicrobial Sulfonamide Allergy Label in Kidney Transplant Recipients
por: Harry Ross Powers, et al.
Publicado: (2025)

Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
por: Madeleine R. Heldman, et al.
Publicado: (2024)

SARS‐CoV‐2‐Specific Antibodies in Pediatric Solid Organ Transplant Recipients: Comment
por: Hinpetch Daungsupawong, et al.
Publicado: (2025)

Single-Center Outcomes of Epstein–Barr Virus DNAemia in Adult Solid Organ Transplant Recipients
por: Sara W. Dong, et al.
Publicado: (2024)

Induction Regimens and Kidney Re‐Transplant Outcomes after BK Nephropathy–Related Graft Loss: A U.S. Cohort Study
por: Rasha El‐Rifai, et al.
Publicado: (2026)